-
Is Eliquis Really A Safe Alternative To Warfarin For A Patient On Hemodialysis, One Pharmacist Wonders
The Prescribing Information For Eliquis Suggests Such Use Is Safe, But There Is Limited Clinical Study Data In Support (Posted by Tom Lamb at DrugInjuryWatch.com) _________________________________________ UPDATE: Here are two new…
-
Eliquis May Appear To Be Safer Than Xarelto, But There Is No Randomized Head-To-Head Clinical Trials Comparing The Two, Yet
One Unfortunate Fact These Two New Blood-Thinners Have In Common Is That Neither Has An FDA-Approved Antidote At Present Time (Posted by Tom Lamb at DrugInjuryWatch.com) Earlier this month the medical journal…
-
Viagra MDL For Melanoma Side Effect Legal Claims May Expand To Include Cialis Lawsuits, Soon, And Levitra Cases, Later
There Is An Apparent Melanoma Skin Cancer Link For Each Of These ED Drugs Given How PDE5 Inhibition Augments Tumor Cell Invasiveness (Posted by Tom Lamb at DrugInjuryWatch.com) _________________________________________________________________________________ UPDATE: IN RE: Viagra…
-
Risk of Hepatitis B Reactivation Associated With Gleevec, Iclusig, And Other BCR-ABL Tyrosine Kinase Inhibitors, According To Health Canada
While Mechanism And Frequency Currently Unknown, This Situation Can Involve Acute Hepatic Failure Or Fulminant Hepatitis Leading To Liver Transplantation Or Death (Posted by Tom Lamb at DrugInjuryWatch.com) Back in May 2016…
-
Harvoni, Sovaldi, Viekira Pak, And Other Direct-Acting Antivirals Get Black-Box Warning: Risk Of Hepatitis B Virus Reactivation
October 2016 FDA Drug Safety Communication Warns About These Relatively New Drugs Which Are Increasingly Popular For Treating Chronic Hepatitis C (Posted by Tom Lamb at DrugInjuryWatch.com) UPDATE: “New Safety Issue:…
-
Savaysa Label Change In September 2016 Points Out There Is No Established Way To Reverse Its Anticoagulant Effects
Use Of Prothrombin Complex Concentrates (PCC) Or Other Procoagulant Reversal Agents Have Not Been Evaluated In Clinical Outcome Studies (Posted by Tom Lamb at DrugInjuryWatch.com) In relevant part, from a September 15, 2016…
